Renova's Electricity Sales Rise in May

Renova's (TYO:9519) renewable energy power plants in Japan sold a combined 184.3 million kilowatt-hours of electricity in May, an increase of 88% from the year-ago period and higher than the targeted

MT NewswiresJun 13 07:31 ET

List of Conversion Stocks (Part 1) [List of Parabolic Signal Conversion Stocks]

○ List of purchase conversion stocks market code stock name closing price SAR Tokyo Stock Exchange Prime ＜1377＞ Sakata Seed 3340 3250 ＜2220＞ Kameda Confectionery 4070 3890 ＜2281＞ Prima Ham 2383 2293 ＜2384＞ SBSHD 2644 2460 ＜2734＞ Sala 812

Fisco JapanJun 6 18:49 ET

RENOVA, TEIJIN, SOMPO, etc

＜4021＞ Nissan 4534 +100 continues to increase drastically. The day before announced the expansion of treasury stock acquisition quotas and the extension of the acquisition period. An announcement of 1.25 million shares, which is 0.90% of the number of issued shares, and a share repurchase with an upper limit of 5 billion yen was made on 5/13, but now, the maximum acquisition limit has been raised to 2.5 million shares or 10 billion yen. The acquisition period used to be from 5/14 to 7/31, but it was changed to 25/3/31. The reason for the change is flexible capital that also takes stock market trends into account

Fisco JapanMay 29 02:23 ET

INPEX, petroleum resources, etc. (additional) Rating

Upgrade-Bullish Code | Stock Name | Securities Company | Conventional | After Change |------|--------------|--------------|--------------|<4911＞|Shiseido | Yamato | “4” | “3” |＜6525＞|KOKUSAI | Nomura | “Neutral” 　

Fisco JapanMay 28 23:35 ET

Notable stock digest (front field): RENOVA, KOKUSAI, Teijin, etc.

Asahi Kasei ＜3407＞: fell by 1030 yen (-20 yen). The acquisition of Caliditas, a Swedish pharmaceutical company, has been announced. All shares have been acquired through TOB, and it seems that the total acquisition amount is expected to be 173.9 billion yen. Cariditas is developing drugs for kidney disease in the United States and elsewhere. On the company side, it seems that they are aiming for sales of 1 trillion yen in the pharmaceutical and medical device business in fiscal year 30. The final profit and loss of Cariditas for the fiscal year ended 23/12 was in deficit of about 6.8 billion yen, but future sales are expected to expand rapidly

Fisco JapanMay 28 22:54 ET

RENOVA --- sharp decline, target stock price reduction in domestic securities due to deterioration in profitability of biomass power generation

Nomura Securities continues to make “neutral” investment decisions, and the target stock price has been lowered from 1330 yen to 1000 yen. The rebound had been getting stronger over the day before, but it seems that it is being used as a trigger for return sales.

Fisco JapanMay 28 21:39 ET